Department of Surgery, Odense University Hospital
Odense, 5000, Denmark
NCT Number: NCT00511264
Laparoscopic Ultrasound (LUS) is an important part of the pre-treatment evaluation of patients with upper gastrointestinal tract cancer (esophageal, gastric, pancreatic and liver cancer). When a suspect lesion is visualized during LUS a biopsy should be provided in order to differentiate between benign and malignant lesions. A new system for LUS guided biopsy has been developed, but how often these biopsies are clinically relevant (i.e. changing patient management)and how reliable are these biopsies are unknown.
The study hypothesis is that LUS guided biopsies are accurate and clinically relevant in the pre-treatment evaluation of patients with upper gastrointestinal tract cancer.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Odense, 5000, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Odense University Hospital
Other
Prospective Evaluation of the Impact of Laparoscopic Ultrasound (LUS) Guided Fine-Needle Aspiration or Tru-Cut Biopsy in Patients With Upper GI Tract Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01033695
Digestive System Diseases, Digestive System Neoplasms
Odense, Denmark
View Trial DetailsNCT07059884
Adnexal Diseases, Anal Cancer
Dublin, California, United States
View Trial DetailsNCT06787807
Adnexal Diseases, Biliary Tract Diseases
Recife, Pernambuco, Brazil
View Trial DetailsNCT02349412
Adenoma, Anxiety Disorder
La Jolla, California, United States
View Trial Details